These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2223007)

  • 61. Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes.
    Harris RJ; Pettitt AR; Schmutz C; Sherrington PD; Zuzel M; Cawley JC; Griffiths SD
    J Immunol; 2000 Apr; 164(7):3887-93. PubMed ID: 10725751
    [TBL] [Abstract][Full Text] [Related]  

  • 62. More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.
    D'Arena G; Guariglia R; Pietrantuono G; Villani O; Martorelli MC; Mansueto G; Criscuolo C; Pierri T; Musto C; Musto P
    Leuk Lymphoma; 2014 Aug; 55(8):1955-7. PubMed ID: 24152050
    [No Abstract]   [Full Text] [Related]  

  • 63. Smudge cells, serum albumin, and prognosis in B-cell chronic lymphocytic leukemia.
    Go RS
    J Clin Oncol; 2009 Aug; 27(22):e44; author reply e45. PubMed ID: 19581530
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemia.
    Call TG; Stenson MJ; Witzig TE
    Leuk Lymphoma; 1994 Jun; 14(1-2):145-9. PubMed ID: 7920222
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells.
    Muzio M; Scielzo C; Frenquelli M; Bachi A; De Palma M; Alessio M; Ghia P; Caligaris-Cappio F
    Leukemia; 2007 Sep; 21(9):2067-70. PubMed ID: 17508001
    [No Abstract]   [Full Text] [Related]  

  • 66. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lymphocytic clusters in peripheral blood: an atypical morphologic pattern of chronic lymphocytic leukemia.
    Bizzaro N; Piazza I
    Acta Haematol; 1991; 86(4):209-11. PubMed ID: 1805489
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
    Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
    J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
    [TBL] [Abstract][Full Text] [Related]  

  • 69. B-lymphocytic infiltration of the prostate to a patient with chronic lymphocytic leukemia. A case report.
    Anastasiou I; Skoufias S; Katafigiotis I; Skarmoutsos I; Constantinides CA
    Arch Ital Urol Androl; 2017 Mar; 89(1):83-84. PubMed ID: 28403603
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What is the CLL B-lymphocyte?
    Dighiero G; Kipps T; Schroeder HW; Chiorazzi N; Stevenson F; Silberstein LE; Caligaris-Cappio F; Ferrarini M
    Leuk Lymphoma; 1996 Oct; 22 Suppl 2():13-39. PubMed ID: 9021706
    [No Abstract]   [Full Text] [Related]  

  • 71. [Morphometric analysis of lymphocyte nuclei in chronic lymphocytic leukemia].
    Ostapenko VA; Kruchinskiĭ NG; Smirnova LA; Cherednik AB; Nesterov VN; Tepliakov AI
    Gematol Transfuziol; 1994; 39(4):15-7. PubMed ID: 7875513
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhanced clearance of leukemic lymphocytes in B-cell chronic lymphocytic leukemia with etodolac.
    Nardella FA; LeFevre JA
    Blood; 2002 Apr; 99(7):2625-6. PubMed ID: 11926185
    [No Abstract]   [Full Text] [Related]  

  • 73. Dameshek W. Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood. 1967;29(4):566-584.
    Blood; 2016 Jul; 128(4):465. PubMed ID: 27471229
    [No Abstract]   [Full Text] [Related]  

  • 74. Practice guidelines on the reporting of smudge cells in the white blood cell differential count.
    Macdonald D; Richardson H; Raby A
    Arch Pathol Lab Med; 2003 Jan; 127(1):105. PubMed ID: 12562274
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of cortisol on the ultrastructure of normal, leukemic, and cultured human lymphocytes.
    Werthamer S; Amaral L
    In Vitro; 1975; 11(4):212-23. PubMed ID: 1176157
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Erythrophagocytosis by lymphocytes in chronic lymphocytic leukemia.
    Wang S; Bo J
    Int J Lab Hematol; 2024 Jun; 46(3):421-422. PubMed ID: 37855188
    [No Abstract]   [Full Text] [Related]  

  • 77. “Rod-Like” Cytoplasmic Crystals of Peripheral Lymphocytes in Chronic Lymphocytic Leukemia.
    Hao J; Gao J; Yang Y; An Z; Lian X
    Turk J Haematol; 2023 Aug; 40(3):202-203. PubMed ID: 37278341
    [No Abstract]   [Full Text] [Related]  

  • 78. Intracytoplasmic crystalline inclusions in peripheral blood lymphocytes in small lymphocytic lymphoma.
    Roldán Galiacho V; Zaldumbide Dueñas L; Lobo Olmedo A; Alonso Varela M; García-Ruiz JC
    Br J Haematol; 2022 Oct; 199(1):8. PubMed ID: 35861146
    [No Abstract]   [Full Text] [Related]  

  • 79. Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia.
    Ferrer G
    EBioMedicine; 2018 Oct; 36():7-8. PubMed ID: 30219356
    [No Abstract]   [Full Text] [Related]  

  • 80. Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells.
    Maffei R; Benatti S; Atene CG; Debbia G; Zucchini P; Potenza L; Luppi M; Fiorcari S; Marasca R
    Leuk Lymphoma; 2020 Feb; 61(2):455-459. PubMed ID: 31724453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.